Robert T. Brooke

Robert T. Brooke is a declared insider at 2 companies; the most frequent names are Iovance Biotherapeutics, Inc. and Range Impact, Inc. Over a trading history stretching from 18 March 2010 to 15 July 2016, the count stands at 5 filings.

No open-market sale appears; the market trades are 1 purchase worth €4,308. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant.

Most recently, on 25 April 2019, the filings show a share grant in Range Impact, Inc. The last purchase on record was published on 21 March 2012, which is 5,346 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 19 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.